This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Il Dong Pharmaceutical Co., Ltd.. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Ilji Jeong: Innovator in CFTR Modulation
Introduction
Ilji Jeong is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate the cystic fibrosis transmembrane conductance regulator (CFTR).
Latest Patents
Ilji Jeong holds a patent for "Substituted pyrazolo[1,5-a]pyrimidines as CFTR modulators." This patent provides CFTR modulator and phosphodiesterase 4 (PDE4) inhibitor compounds, which can be utilized for treating eye diseases and CFTR-related indications. The compounds described in the patent also offer methods for inhibiting PDE4 in biological systems, addressing inflammatory diseases, and preparing synthetic precursors.
Career Highlights
Ilji Jeong is associated with Il Dong Pharmaceutical Co., Ltd., where he has been instrumental in advancing research and development in pharmaceutical compounds. His work focuses on innovative solutions for complex medical conditions.
Collaborations
Ilji Jeong collaborates with esteemed colleagues, including Myongjae Lee and Changmok Oh, to enhance the scope and impact of his research.
Conclusion
Ilji Jeong's contributions to CFTR modulation and his innovative approach to pharmaceutical development underscore his importance in the field. His work continues to pave the way for advancements in treating various medical conditions.